CSTL
CASTLE BIOSCIENCES INC
Nasdaq Services-Medical Laboratories Accelerated filer

Key Financials

Revenue
$344.2M
↑ 3.7%
Gross Profit
$53.0M
↑ 262.1%
Operating Income
$-42810000
↓ 593.8%
Net Income
$-24158000
↓ 232.4%
Shareholders' Equity
$470.9M
↑ 3.3%
Cash & Equivalents
$116.7M
↓ 2.5%
EPS (Diluted)
$-0.83
↓ 233.9%
Total Assets
$578.6M
↑ 8.9%

Recent SEC Filings

Form Type Filed Date Link
144 7/1/2026 View on SEC
4 6/18/2026 View on SEC
4 6/17/2026 View on SEC
144 6/16/2026 View on SEC
4 6/3/2026 View on SEC
144 6/1/2026 View on SEC
4 6/1/2026 View on SEC
4 6/1/2026 View on SEC
4 6/1/2026 View on SEC
4 6/1/2026 View on SEC

Company Information

Field Value
Ticker CSTL
Company Name CASTLE BIOSCIENCES INC
CIK 1447362
Sector Services-Medical Laboratories
Industry Accelerated filer
Exchange Nasdaq
SIC Code 8071
SIC Description Services-Medical Laboratories
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 866-788-9007